Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma
PLOS ONE · 04.01.2023 · 18 (1) · e0280023
DOI: 10.1371/journal.pone.0280023 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 04.01.2023. Verfasst von Chan-Keng Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cytokine-Induced Killer Cells, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, Ministry of Science and Technology.
Abstract (Originalsprache)
Background
Cytokine-induced killer (CIK) cells are heterogeneous lymphocytes from human peripheral blood mononucleated cells (PBMCs) co-cultured with several cytokines. The main purpose of this study is to evaluate the functional characteristics and anticancer ability of CIK cells from hepatocarcinoma (HCC) patients.
Methods
CIK cells were activated ex-vivo and expanded from PBMCs from HCC patients. The immunophenotype and the ex-vivo killing ability of CIK cells were evaluated. Human CIK cells were intravenously injected into NOD/SCID mice to evaluate the in vivo anticancer ability.
Results
More than 70% of CIK cells were CD3+CD8+, and 15%–30% were CD3+CD56+. These cells expressed an increased number of activated natural killer (NK) receptors, such as DNAM1 and NKG2D, and expressed low-immune checkpoint molecules, including PD-1, CTLA-4, and LAG-3. Among the chemokine receptors expressed by CIKs, CXCR3 and CD62L were elevated in CD8+ T cells, representing the trafficking ability to inflamed tumor sites. CIK cells possess the ex-vivo anticancer activity to different cell lines. To demonstrate in vivo antitumor ability, human CIK cells could significantly suppress the tumor of J7 bearing NOD/SCID mice. Furthermore, human immune cells could be detected in the peripheral blood and on the tumors after CIK injection.
Conclusions
This study revealed that CIK cells from HCC patients possess cytotoxic properties, and express increased levels of effector NK receptors and chemokine molecules and lower levels of suppressive checkpoint receptors. CIK cells can suppress human HCC ex-vivo and in vivo. Future clinical trials of human CIK cell therapy for HCC are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan.
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kweishan, Taoyuan, Taiwan.
- Division of Gastroenterology-Hepatology, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan.
- Department of Pathology, Linkou Medical Center, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan.
- College of Medicine, Chang Gung University, Kweishan, Taoyuan, Taiwan.
ORCID-Profile: Tse-Ching Chen, Yung-Chang Lin, Chun-Yen Lin
Förderung
- Chang Gung Memorial Hospital
- Ministry of Science and Technology
Zitieren
APA
Yang, C. K., Huang, C. H., Hu, C. H., Fang, J. H., Chen, T. C., Lin, Y. C., & Lin, C. Y. (2023). Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma. PLOS ONE, 18(1), e0280023. https://doi.org/10.1371/journal.pone.0280023
Vancouver
Yang CK, Huang CH, Hu CH, Fang JH, Chen TC, Lin YC, et al. Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma. PLOS ONE. 2023;18(1):e0280023. doi:10.1371/journal.pone.0280023
BibTeX
@article{Yang2023,
author = {Yang, Chan-Keng and Huang, Chien-Hao and Hu, Ching-Hsun and Fang, Jian-He and Chen, Tse-Ching and Lin, Yung-Chang and Lin, Chun-Yen},
title = {Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {1},
pages = {e0280023},
doi = {10.1371/journal.pone.0280023}
}
EUVIMED